Catalytic promiscuity: catecholase-like activity and hydrolytic DNA cleavage promoted by a mixed-valence Fe^IIIFe^II complex

Ademir Neves^*,I; Adailton J. Bortoluzzi^I; Rafael Jovito^I; Rosely A. Peralta^I; Bernardo de Souza^I; Bruno Szpoganicz^I; Antônio C. Joussef^I; Hernán Terenzi^II; Patricia C. Severino^II; Franciele L. Fischer^II; Gerhard Schenk^III; Mark J. Riley^III; Sarah J. Smith^III; Lawrence R. Gahan^III

^ILABINC, Departamento de Química
^IICentro de Biologia Molecular Estrutural, Departamento de Bioquímica, Universidade Federal de Santa Catarina, 88040-900 Florianópolis-SC, Brazil
^IIISchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane 4072, Australia

ABSTRACT

Catalytic promiscuity has emerged as an important property of many enzymes since the relationship of this property to enzymatic evolution became clear. Simultaneously, the development of suitable biomimetic catalytic systems capable of mimicking the promiscuous catalytic properties of such enzymes represents a new challenge for bioinorganic chemists. In this paper we report on the X-ray structure, the solution studies and the promiscuous catalytic activity of the mixed-valence complex [(bpbpmp)Fe^III(µ-OAc)₂Fe^II](ClO₄), (1), containing the unsymmetrical dinucleating ligand 2-{[(2-hydroxybenzyl)(2-pyridylmethyl)aminomethyl]-4-methyl-6-[bis(2-pyridylmethyl)aminomethyl]}phenol (H₂bpbpmp). Potentiometric and spectrophotometric titrations and kinetics studies showed that this coordination compound generates active species that promote hydrolytic cleavage of double strand DNA (dsDNA), with a rate enhancement of 1.9×10⁸ over the non-catalyzed reaction, as well as promote oxidation of 3,5-di-tert-butylcatechol (3,5-dtbc), with k_cat = 1.16 × 10^-2 s^-1 and K_M = 7.1×10^-4 mol L^-1. Thus, complex 1 shows both hydrolase and oxidoreductase activities and can be regarded as a man-made model for studying catalytic promiscuity.

Keywords: mixed-valence Fe^IIIFe^II complex, unsymmetrical ligand, catalytic promiscuity, diester and DNA cleavage, catecholase activity

RESUMO

Os estudos sobre enzimas têm mostrado que existe uma relação clara entre a evolução enzimática e a propriedade de promiscuidade catalítica que elas podem apresentar. Com isto, o desenvolvimento de sistemas biomiméticos capazes de atuar de modo promíscuo, de forma similar a algumas enzimas, mostrou-se um novo desafio para os químicos bioinorgânicos. Neste trabalho, reportamos a estrutura de raios X e os estudos em solução e de promiscuidade catalítica do complexo [(bpbpmp)Fe^III(µ-OAc)₂Fe^II](ClO₄), (1), contendo o ligante binucleante não-simétrico 2-{[(2-hidroxibenzil)(2-piridilmetil)aminometil]-4-metil-6-[bis(2-piridilmetil)aminometil]}fenol (H₂bpbpmp). Estudos de titulações potenciométrica e espectrofotométrica e cinéticos mostraram que esse composto de coordenação gera espécies ativas capazes de clivar o dsDNA (DNA de fita dupla) hidroliticamente, com um aumento de 1,9×10⁸ na taxa de reação em comparação com a reação não catalisada, e capazes de oxidar o 3,5-di-terc-butilcatecol (3,5-dtbc), com k_cat = 1,16 × 10^-2 s^-1 e K_M = 7,1×10^-4 mol L^-1. Assim, o complexo 1 apresenta atividades de hidrolase e oxidoredutase, sendo um interessante modelo sintético para estudos de promiscuidade catalítica.

Introduction

Catalytic promiscuity means, in the broadest sense, the ability of a given natural or non-natural active site to catalyze more than one chemical transformation. It constitutes a very important property of many enzymes, having a natural role in evolution and, occasionally, in the biosynthesis of secondary metabolites.^1-7 For example, it has been demonstrated that vanadium-dependent chloroperoxidase shows phosphatase activity when vanadate is not present, indicating that its active site is very similar to that of the acid phosphatases.⁸ On the other hand, it was found that an acid phosphatase from plants (in contrast to the kidney bean purple acid phosphatase (PAP)) uniquely exhibits chloroperoxidase activity with loss of phosphatase activity when orthovanadate is added to the apo form of the enzyme.⁹ Although these activities constitute very different overall reactions, they involve enzyme-bound species that are structurally related. Furthermore, it has been demonstrated that the PAP isolated from tomato may act as a bifunctional enzyme that operates in the hydrolysis of phosphate-esters and also displays significant alkaline peroxidase activity with the involvement of reactive oxygen species.¹⁰ Indeed, several plant PAPs have been reported to be expressed in response to pathogen attack or elicitor treatment.^11,12 Nevertheless, no catecholase activity for any of the well characterized PAPs has as yet been described. While several enzymes displaying catalytic promiscuity have been the subject of recent related investigations,^1-7 there are few examples of synthetic analogues which exhibit such multifunctional activities.^13-18

For example, it has been established that the [(bpbpmp)Fe^III(µ-OAc)₂Fe^II](ClO₄)•H₂O complex, (1), is a good model for the electrochemical properties of uteroferrin, with a reduction potential for the Fe^IIIFe^III to Fe^IIIFe^II couple of 380 mV (versus the normal hydrogen electrode, NHE), which compares well with the 344 mV measured for uteroferrin at pH 4.1 via direct electrochemistry and 367 mV at pH 5 via microcoulometry.^{9, 33,34} It has also been well documented that complex 1 and its corresponding oxidized complex [(bpbpmp)Fe^III(µ-OAc)₂Fe^III](ClO₄)₂, (2), are good models for the resonance Raman properties of mammalian PAPs in their reduced and oxidized forms, respectively.³⁰ In addition, to understand the spectral signatures of the dinuclear center and to relate these to the di-iron enzyme uteroferrin, spectroelectrochemical, spectroscopic, and computational studies, and phosphatase-like reactivity of the [(bpbpmp)Fe^III(µ-OAc)₂Fe^II]⁺ ion complex have also been reported.³¹ Very recently, the [(bpbpmp)Fe^III(µ-OAc)₂Fe^II]⁺ complex has been used as an electrochemical biomimetic sensor for the determination of phenolic compounds.³²

In this study, we describe the X-ray structure and solution studies of the mixed-valence complex [(bpbpmp)Fe^III(µ-OAc)₂Fe^II](ClO₄)•H₂O, (1), which is able to cleave phosphodiester bonds of the activated substrate bis(2,4-dinitrophenyl)phosphate (2,4-bdnpp)³⁵ and of DNA itself, but also shows significant catalytic activity in the oxidation of the model substrate 3,5-di-tert-butylcatechol (3,5-dtbc) and can thus be considered as a promiscuous man-made catalyst.

Experimental

Materials and measurements

The potentiometric studies were carried out with a Micronal 375 pH meter fitted with blue-glass and calomel reference electrodes calibrated to read –log[H⁺] directly, designated as pH. Bidistilled water in the presence of KMnO₄ was used to prepare CH₃CN (1:1 v/v) solutions. The electrode was calibrated using the data obtained from a potentiometric titration of a known volume of a standard 0.0100 mol L^-1 HCl solution with standard 0.100 mol L^-1 KOH. The temperature was kept at 25.00 ± 0.05 ºC, and the ionic strength was adjusted to 0.100 mol L^-1 by addition of KCl. The experimental solutions were titrated with 0.100 mol L^-1 standard CO₂-free KOH. Equilibrium measurements were taken using solutions containing 0.05 mmol of complex. The experiments were performed on 50.00 mL of the CH₃CN:H₂O (1:1 v/v) solution in a thermostated cell purged with argon, using 0.100 mol L^-1 KOH solutions. The experiments were carried out in triplicate. Computations of the triplicates were all carried out with the BEST7 program, and the species diagrams were obtained with SPE and SPEPLOT programs.³⁶

Complexes 1 and 2 were also titrated spectrophotometrically. All titrations were carried out under an argon atmosphere at 25 ºC in 1:1 (v/v) CH₃CN:H₂O. The pH was first adjusted with HCl and the complex titrated with successive additions of CO₂ free KOH 0.124 mol L^-1. At each measured pH, an aliquot was removed to record the UV-Vis spectrum.

A dark red crystal was selected from the sample of complex 1 and fixed at the end of a glass fiber for X-ray analysis. Crystallographic measurements of complex 1 were carried out with an Enraf-Nonius CAD4 diffractometer with graphite-monochromated Mo-K_α radiation, at room temperature. Cell parameters were determined from 25 carefully centered reflections using a standard procedure.³⁷ All data were corrected for Lorentz and polarization effects.³⁸ A semi-empirical absorption correction based on the azimuthal scans of seven appropriate reflections was also applied to the collected intensities with the PLATON program,^39,40 with maximum and minimum transmission factors of 0.873 and 0.791, respectively. The structure was solved by direct methods and refined by full-matrix least-squares methods using SIR97⁴¹ and SHELXL97⁴² programs, respectively. All non-hydrogen atoms were refined anisotropically. H atoms attached to C atoms were placed at their idealized positions, with C-H distances and U_eq values taken from the default settings of the refinement program. The water molecule H atoms were found from a Fourier difference map and treated with the riding model. Two oxygen atoms of the perchlorate counterion are disordered over two alternative positions. The site occupancies of 0.555(14) and 0.445(14) for the disordered atoms were refined and the geometric parameters around the chlorine atom were constrained. Further selected crystallographic data are summarized in Table 1.

Syntheses

The unsymmetric dinucleating ligand H₂bpbpmp was prepared accordingly to procedures previously described in the literature.²³

[(bpbpmp)Fe^III(m-OAc)₂Fe^II](ClO₄)•H₂O, (1)

0.5 mmol of H₂bpbpmp were dissolved in 10 mL of CH₃CN under argon. To this solution were added, respectively, 1 mmol of Fe(ClO₄)₂•6H₂O and 2 mmol of NaOAc in MeOH (10 mL) also under argon. The resulting solution became deep purple. Finally, 5 mL of diisopropyl ether in the presence of air were added to the purple solution, which was kept in the refrigerator. After 24 h crystals suitable for X-ray crystallography were formed, which were collected by filtration (0.32 g, 70 %). Elemental Analysis for C₃₈H₄₁ClFe₂N₅O₁₁ (890.91 g mol^-1): Found C, 51.56; H, 4.60; N, 7.78. Calculated C, 51.23; H, 4.64; N, 7.86%. The compound is stable in air in the solid state. (Caution! As with all perchlorate salts, samples should be handled with care.)

[(bpbpmp)Fe^III(m-OAc)₂Fe^III](ClO₄)₂•3CH₃OH•3H₂O (2)

To a solution of Fe(ClO₄)₃•9H₂O (2.0 mmol) in 20 mL of methanol, sodium acetate trihydrate (2.5 mmol) and H₂bpbpmp (1.07 mmol) were added. The clear dark blue solution was heated to 40 ºC and stirred for 10 min at ambient atmosphere. After cooling of the solution to room temperature, a blue microcrystalline precipitate was formed, which was filtered off and washed with 2-propanol and ether (0.73 g, 65%). Elemental Analysis for C₄₁H₅₇Cl₂Fe₂N₅O₂₀ (1121.17 g mol^-1): Found C, 44.3; H, 4.58; N, 6.24. Calculated C, 43.87; H, 5.12; N, 6.24%.

Catecholase-like activity toward the oxidation of the model substrate 3,5-di-tert-butylcatechol (3,5-dtbc) was investigated. The experiments were followed spectrophotometrically on a Varian Cary50 Bio spectrophotometer connected to a computer, by monitoring the increase in the 3,5-di-tert-butyl-quinone (3,5-dtbq) characteristic absorption band at 400 nm over time. The conversion of the reaction rate units was carried out using ε = 1760 L mol^-1 cm^-1 (measured in the reaction conditions) for 3,5-di-tert-butylquinone, and the initial concentration of complex.

The experiments were carried as follows: a stock solution of the complex was prepared in methanol (16 h earlier), saturated with argon (4.4×10^-4 mol L^-1). A stock solution of the substrate was also prepared in methanol ([3.5-dtbc] = 8.26×10^-2 mol L^-1). To a 4 mL cuvette, 100 µL of argon-saturated buffer and 100 µL of 1 were added. Subsequently, O₂-saturated methanol, deionized water and substrate (20-200 µL) were added to complete 3.0 mL (giving the proportion 1.8 mL methanol : 1.2 mL water, v/v).

The initial rate was obtained from the slope of the absorbance vs. time plot over the first 10 min of reaction. Each experiment was performed at least three times, and the obtained plots were analyzed by the initial rate method. A kinetic treatment using nonlinear Michaelis-Menten approach was applied.

The influence of the pH on the catalyzed oxidation of the 3,5-di-tert-butylcatechol was determined over the pH range of 4.4 to 9.0. Reactions were performed using the following conditions in the cuvette: air saturated CH₃OH/H₂O, 3:2 v/v, [1] = 1.39×10^-5mol L^-1, [3,5-dtbc] = 2.77×10^-3 mol L^-1, [buffer] = 3.3×10^-2 mol L^-1 (Buffer = MES, 2-[N-morpholine]ethanesulfonic acid, or TRIS, tris(hydroxymethyl)aminomethane). Dependence of the reaction rates on [3,5-dtbc] was determined at pH 6.0, in a methanol:water (3:2, v/v) solution. Conditions: [1] = 1.46×10^-5 mol L^-1; [3,5-dtbc] = 0.5-5.5×10^-3 mol L^-1, [buffer] = 3.3×10^-2 mol L^-1 (buffer = MES).

To determine which reduced oxygen species (hydrogen peroxide or water) was formed during the reaction, mixtures were prepared as in the kinetics experiments. After 1 h of reaction an equal volume of H₂SO₄ (5×10^-3 mol L^-1) was added. The quinone was washed twice with dichloromethane (2×3 mL). To a 2 mL aliquot of the aqueous layer a KI solution (1 mL, 0.30 mol L^-1) was added. Finally, ammonium molybdate (0.1 mol L^-1) solution was added in catalytic amounts to specifically accelerate the formation of I₃^– in the presence of H₂O₂. The increase in the I₃^- absorption band at 353 nm (ε = 26,000 L mol^-1 cm^-1) was monitored by UV-Vis spectroscopy.^43-45 The reaction without oxygen was prepared under the kinetic conditions and the absorbance increase at 400 nm due to quinone release was not observed.

DNA extraction

Plasmid DNA (pBSKII) (Stratagene) was produced in Escherichia coli and purified with HiSpeed Maxiprep Kit (Qiagen) following the protocol described by the manufacturer.

DNA cleavage under anaerobic and aerobic conditions

Complex 1 solutions were diluted in acetonitrile in an argon-filled glove bag to avoid Fe oxidation. A two-step procedure was used to obtain deoxygenated water, piperazine-1,4-bis(2-ethanesulfonic acid) (PIPES) buffer and ethylenediaminetetraacetic acid (edta). A parallel experiment with the oxidative cleavage system [Fe(edta)]₂/DTT (dithiothreitol) was used to demonstrate the deoxygenation procedure efficiency.^46,47 DNA cleavage experiments were performed in a final volume of 20 µL containing 35 µmol L^-1 bp (DNA base pairs) pBSK II plasmid DNA, complex 1 [40, 80 and 160 µmol L^-1], 25% acetonitrile (v/v) and 25 mmol L^-1 PIPES buffer, pH 6.0. Reaction mixtures were incubated at 50 ºC for 2 h in a sealed argon-filled vacuum desiccator.

Reactions were stopped by chilling tubes on ice and adding 4 µL of ice-cold loading-buffer (50% glycerol, 0.2 mol L^-1 edta, 0.05% bromophenol blue). Samples were submitted to agarose gel electrophoresis and stained with ethidium bromide. Resulting gels were digitalized with a photo-documentation system (UVP, CA, USA) and DNA bands were quantified using LabWorks software version 4.0 (UVP).

Kinetics DNA assays

DNA cleavage reactions were performed at 50 ºC in 25 mmol L^-1 PIPES (pH 6.0), using 35 µmol L^-1 bp (DNA base pairs) pBSK II plasmid DNA at concentrations of complex 1 ranging from 0 to 160 µmol L^-1, in a final volume of 160 µL. Aliquots of 20 µL were withdrawn at different time intervals (0-60 min) and were analyzed as described for the DNA cleavage.^{22, 48}

Reaction mechanism

Cleavage experiments to understand the reaction mechanism were carried out with potential inhibiting agents such as a hydroxyl radical scavenger dimethyl sulfoxide (dmso), a singlet oxygen scavenger (sodium azide, NaN₃) and a minor groove binder (distamycin).^7,49-51

Reactions in the presence of the above compounds were carried out in 20 µL final volume, containing: 35 µmol L^-1 bp (plasmid DNA), in 25 mmol L^-1 PIPES, pH 6.0, for 1 h at 50 ºC (other conditions are described in the Figure legends). Reactions were stopped by chilling tubes on ice and adding 4 µL of ice-cold loading-buffer. Samples were analyzed in 0.8% agarose gel.

Results and Discussion

Synthesis of 1 and 2 and crystal structure of 1

The structure of complex 1 consists of discrete dinuclear [Fe^III(bpbpmp)(µ-OAc)₂Fe^II]⁺ cations, uncoordinated perchlorate anions and one molecule of water in the crystallographic asymmetric unit. An ORTEP drawing of 1 with its atom-labeling scheme is shown in Figure 1. Selected bond distances and angles are given in Table 2.

The structure of the cation [Fe^III(bpbpmp)(µ-OAc)₂Fe^II]⁺ in 1 is similar to that determined for the corresponding BF₄^- salt.³¹ Briefly, in the structure of [Fe^III(bpbpmp)(µ-OAc)₂Fe^II]⁺ the metal centers are bridged by the phenolate oxygen atom of the bpbpmp^2- ligand and by two exogenous acetate ligands, as has been observed in numerous isostructural complexes containing the same ligand.^22-29 As expected for a dinuclear mixed-valence complex containing the unsymmetrical bpbpmp^2- ligand, the coordination sphere of the Fe^III is completed by two nitrogen atoms from the tertiary amine (N1) and pyridyl (N22) groups, and by a terminal phenolate oxygen (O10), while the Fe^II is on the softer side of bpbpmp^2-, coordinated by three nitrogen atoms, pyridyl N32 and N42 and tertiary amine N2.

The bridging O_phenolate is coordinated unsymmetrically to the two metal centers, with the bond distances Fe^III-O = 2.005(3) and Fe^II-O = 2.102(3) Å being slightly longer than those observed in the mixed-valence complex [Fe^IIIFe^II(bpmp)(OPr)₂]²⁺ (Fe^III-O = 1.943(2) and Fe^II-O1 = 2.090(2) Å) containing the symmetric Hbpmp (2,6-bis[(bis(2-pyridylmethyl)amino)methyl]-4-methylphenol) ligand.²⁹ As in the analogous Fe^IIIM^II complexes (M^II = Zn, Cu, Ni, Mn), the terminal phenolate coordinated to the Fe^III is trans to the bridging phenolate. The metal-metal distance (3.5041(13) Å) as well as the Fe^III-O-Fe^II angle (117.14(13)º) in the Fe^IIIFe^II complex are similar to those observed in all of the isostructural Fe^IIIM^II complexes (3.470-3.510 Å and 115-119º).^22-29 Additionally, the terminal phenoxo–Fe^III-O_phenolate bond length (1.902(3) Å) in 1 is slightly longer than the corresponding bond in the Fe^IIIZn^II complex (1.890 Å).⁵²

Solution studies of 1 and 2

Potentiometric titration studies of the complex [Fe^III(bpbpmp)(µ-OAc)₂Fe^II]ClO₄(1) in 1:1 acetonitrile/buffer have been described previously and showed the presence of four protonation equilibria, two of which (pK_a2 = 4.13 and pK_a4 = 7.53) are catalytically relevant for the hydrolysis of phosphate diester bonds.³¹ Results are summarized in Table 3, with the kinetic pK_as of 1 for comparison.

Deprotonation of the water molecule (pK_a2 = 3.14) coordinated to the Fe^III center containing the softer terminal tridentate group (one amine and two pyridine) leads to the formation of the [(OH₂)Fe^III(µ-OH)Fe^III(OH)] species (structure B in Scheme 2). This observation is based mainly on the fact that the Fe^III center bound by three nitrogens of bpbpmp^2- is a stronger Lewis acid than the Fe^III center coordinated by the harder N₂O-donor pendant arm containing the terminal phenolate group. The pK_a3 of 4.22 is attributed to dissociation of the bridging µ-OH group which results in the formation of [(OH₂)Fe^III(µ-O)Fe^III(OH)] (structure C in Scheme 2) as one of the catalytically active species in the oxidation of catechols (vide infra). This pK_a value is around 1.5 pH units lower than the corresponding pK_a determined in the mixed-valence Fe^IIIFe^II complex 1 and can be explained in terms of a higher Lewis acidity exerted by two Fe^III centers on the bridging µ-OH group in complex 2. Deprotonation of the water molecule (pK_a4 = 6.45) terminally coordinated to the Fe^III center which contains the harder tridentate N₂O-donor group (one amine, one pyridine and one phenolate) leads to the formation of the [(OH)Fe^III(µ-O)Fe^III(OH)] species (structure D in Scheme 2) which is the most active catalyst in the oxidation of catechols. Again, as expected, this pK_a4 = 6.45 is approximately one pH unit lower when compared to the protonation/deprotonation equilibrium found for the corresponding Fe^II-OH₂ bond in the mixed-valence complex 1. Moreover, it is also important to note that this pK_a4 value is in good agreement with the pK_a of 7.0 determined for the dissociation of the second Fe^III-bound water molecule in a dinuclear Fe^III complex which contains a similar NO-donor set as that proposed for the [(OH₂)Fe^III(µ-O)Fe^III(OH)] species.⁵³ Finally, a fourth deprotonation/protonation equilibrium at pK_a5 = 9.65 was observed, despite the fact that in the [(OH)Fe^III(µ-O)Fe^III(OH)] species there appears to be no ionizable protons under these experimental conditions. We tentatively suggest the substitution of one pyridine group bound to one of the Fe^III centers by one water molecule with subsequent deprotonation of this water molecule as being responsible for this equilibrium.⁵³

Spectrophometric titration of the mixed-valence complex 1 reveals four protonation/deprotonation constants which are comparable to those obtained from the potentiometric experiments (Table 3, Figure S1).³¹ In general, hypsochromic shifts are detected (Figure 3) when the pH of the solution rises, suggesting that the replacement of Fe^III-OH₂ by Fe^III-OH, or of Fe^III(µ-OH)Fe^III by Fe^III(µ-O)Fe^III in the systems in equilibrium does affect the energy of the LMCT processes. This is probably due to a lower order of Lewis acidity of the Fe^III-centers when the stronger donor hydroxo or oxo groups are coordinated, so that the t_2g orbitals in these species are at higher energy than the t_2g orbitals in the Fe^III-OH₂ complexes. Similarly, spectrophotometric titration of the oxidized form of complex 2 also demonstrates that the λ_max of the LMCT is strongly influenced by the pH of the solution (Figure S2, Figure S3). However, in this case only three reliable pK_a values (Table 3) could be obtained in the pH range of 2.4-10.9, which are in good agreement with those calculated in the potentiometry studies.

Kinetics

In recent years, it has been demonstrated that many enzymes are able to catalyze distinctly more than one chemical reaction. This ability, called catalytic promiscuity, may be related to different kinds of bond formation or cleavage or different catalytic pathways or even both.^1,54 Biomimetic models can be more susceptible to catalytic promiscuity, since they do not have a complex structure as do enzymes. In this regard, biomimetic models are expected to be much more accessible to different substrates and more dependent on the environmental conditions.

The catalytic promiscuity of the complex [Fe^III(bpbpmp)(m-OAc)₂Fe^II]ClO₄, (1), was evaluated by testing its hydrolase-like activity in the cleavage of DNA and its catecholase-like activity toward the oxidation of the model substrate 3,5-di-tert-butylcatechol (3,5-dtbc).³¹ The phosphatase-like activity of 1 in the hydrolysis of the model substrate bis-2,4-dinitrophenylphosphate (2,4-bdnpp) has been demonstrated very recently.³¹

The catecholase activity of complexes 1 and 2 was determined using the substrate 3,5-di-tert-butylcatechol by following spectrophotometrically the absorbance increase due to the formation of 3,5-di-tert-butylquinone (λ_max = 400 nm), under conditions of excess substrate. It is important to note that there is no reaction (not even one cycle) using 1 as the catalyst during a period of three hours in the absence of oxygen. However, after this time, if the cuvettes were opened to allow the entrance of oxygen, the reaction begins immediately. Therefore, the kinetics data obtained suggest the formation of an oxidized form of Fe^IIIFe^III as the catalyst, which can be obtained through oxidation of 1 in the presence of air or through chemical oxidation of 1 with H₂O₂ or from the dissolution of the complex 2 in kinetic conditions. Indeed, the spectrum of 1 under kinetic conditions without the substrate shows the disappearance of the intervalence band centered at 1100 nm, indicating that the species [(OH₂)Fe^III(µ-O)Fe^II(OH)] is oxidized to complex[(OH₂)Fe^III(µ-O)Fe^III(OH)]in the presence of air (Figure S4).

The dependence of the initial rates on the concentration of 3,5-dtbc using complex 1 as the catalyst was investigated at 25 ºC at pH 6.0 and revealed saturation kinetics with Michaelis-Menten-like behavior (Figure 5).

Finally, papers found in the literature related to catechol artificial biomimetics generally refer to binuclear Cu^II complexes.^43-45,55 It is interesting to note that the kinetic parameters obtained in this study for complex 1 orcomplex 2 are of the same order as those found for Cu^IICu^II complexes with similar ligands, but with 1 or 2 being active at lower pH values (6.0 vs. 8-9),^43-45 which is a consequence of the higher Lewis acidity of Fe^III when compared to Cu^II.

Considering all of the experimental data obtained, the mechanism shown in Scheme 3 is proposed.

DNA cleavage

To verify the ability of complex 1 to cleave DNA phosphodiester bonds, we tested its activity in the absence and in the presence of oxygen. Data from the experiments under aerobic and anaerobic conditions (Figure 6) suggest that a hydrolytic mechanism is responsible for the DNA cleavage, since the reaction is not affected by the absence of oxygen. The control experiment with Fe(edta)^2–/dithiothreitol demonstrated that there is no residual oxygen because DNA cleavage was totally inhibited under anaerobic conditions.

It is also clear from Figure 6 that 1 was able to cleave plasmid DNA in a concentration-dependent manner. An increase in circular (nicked, form II) plasmid DNA, and a proportional decrease in supercoiled DNA (form I) was observed with increasing complex concentration.

Figure 8 presents the results of DNA cleavage by 1 in the presence of potential inhibiting agents: a hydroxyl radical scavenger (dmso), a singlet oxygen scavenger (sodium azide, NaN₃) and a DNA minor groove binder (distamycin). Neither dmso nor sodium azide interfered with the cleavage activity of the complex. These results are in agreement with those found under anaerobic conditions, demonstrating that 1 cleaves DNA hydrolytically and that oxygen radicals are not involved in the reaction. Also in Figure 8, the activity of 1 is not inhibited by distamycin, suggesting that 1 interacts with double strand DNA through the major grove.

The complexes [(bpbpmp)Fe^III(µ-OAc)₂Fe^II](ClO₄) (1) and [(bpbpmp)Fe^III(µ-OAc)₂Fe^III](ClO₄)₂ (2) containing the unsymmetrical dinucleating ligand H₂bpbpmp, 2-{[(2-hydroxybenzyl)(2-pyridylmethyl)aminomethyl]-4-methyl-6-[bis(2-pyridylmethyl)aminomethyl]}phenol, were synthesized and their properties and catalytic features explored. The X-ray structure of 1 reveals an {Fe^III(µ-O_phenolate)(µ-OAc)₂Fe^II} core in which the Fe^III and Fe^II metal centers are, respectively, bound by the hard and soft side of the bpbpmp^2- ligand. Kinetic studies on the cleavage of double strand DNA (dsDNA) by 1 at the optimum pH (6.0) and 50 ºC show Michaelis-Menten behavior with a rate enhancement of 1.9×10⁸ over the uncatalyzed reaction. Data from the experiments under aerobic and anaerobic conditions along with kinetic studies on a model diester substrate suggest a hydrolytic mechanism in which a terminal Fe^III-bound hydroxide is the initiating nucleophile in the catalytic reaction. On the other hand, when the [(bpbpmp)(HO)Fe^III(µ-OH)Fe^II(H₂O)]⁺ species is exposed to air, the oxidized Fe^IIIFe^III complex is formed. This complex shows significant catecholase activity in the oxidation of 3,5-di-tert-butylcatechol (methanol/water buffer, 60:40, pH = 5.8) and the reaction follows Michaelis-Menten behavior with k_cat = 1.16×10^-2 s^-1 and K_M = 7.1×10^-4 mol L^-1. The complex is thus revealed to be an important example of a synthesized promiscuous catalyst, with activity in both the oxidation of catechols and the hydrolysis of phosphodiester bonds.

Supplementary Information

Figures S1-S4 are available free of charge at http://jbcs.sbq.org.br, as a PDF file. Crystallographic data (excluding structural factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 747619. Copies of the data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK ; fax: +44 1223 336033 ; or e-mail: deposit@ccdc.cam.ac.uk).

Acknowledgments

The authors thank CNPq, CAPES, FAPESC and INCT-Catálise for financial support. G. Schenk and L. Gahan acknowledge funds awarded by the Australian Research Council through grants DP0986292, DP0986613, DP0664039 and DP0558652.

References

1. Kazlauskas, R. J.; Curr. Opin. Chem. Biol. 2005, 9, 195.         [ Links ]

2. Bornscheuer, W. T.; Kazlauskas, R. J.; Angew. Chem. 2004, 43, 6032.         [ Links ]

3. O'Brian, P. J.; Herschlag, D.; Chem. Biol. 1999, 6, 91.         [ Links ]

4. Taglieber, A.; Höbenreich, H.; Carballeira, J. D.; Mondière, R. J. G.; Reetz, M. T.; Angew. Chem. 2007, 46, 8597 and references therein.         [ Links ]

5. O'Brian, P. J.; Chem. Rev. 2006, 106, 720 and references therein.         [ Links ]

6. Olguin, L. F.; Askew, S. E.; O'Donoghue, A. C.; Hollfelder, F.; J. Am. Chem. Soc. 2008, 130, 16547.         [ Links ]

7. Zalatan, J. G.; Herschlag, D.; J. Am. Chem. Soc. 2006, 128, 1293.         [ Links ]

8. Hemrika, W.; Renirie, R.; Dekker, H. L.; Barnett, P.; Wever, R.; Proc. Natl. Acad. Sci. USA 1997, 94, 2145.         [ Links ]

9. Yoneyama, T.; Shiozawa, M.; Nakamura, M.; Suzuki, T.; Sagane, Y. Katoh, Y.; Watanabe, T.; Ohyama, T.; J. Biol. Chem. 2004, 279, 37477.         [ Links ]

10. Bozzo, G. G.; Raghothama, K. G.;. Plaxton, W. C.; Eur. J. Biochem. 2002, 269, 6278.         [ Links ]

11. Kenton, P.; Mur, L. A. J.; Draper, J.; J. Exp. Bot. 1999, 50, 1331.         [ Links ]

12. Jakobek, J. L.; Lindgren, P. B.; J. Exp. Bot. 2002, 53, 387.         [ Links ]

13. Oliveira, M. C. B.; Scarpellini, M.; Neves, A.; Terenzi, H.; Bortoluzzi, A. J.; Szpoganicz, B.; Greatti, A.; Mangrich, A. S.; Souza, E. M.; Fernandez, P. M.; Soares, M.; Inorg. Chem. 2005, 44, 921.         [ Links ]

14. Rey, N. A.; Neves, A.; Bortoluzzi, A. J.; Pich, C. T.; Terenzi, H.; Inorg. Chem. 2007, 46, 348.         [ Links ]

15. Deck, K. M.; Tseng, T. A.; Burstyn, J. N.; Inorg. Chem. 2002, 41, 669.         [ Links ]

16. Hegg, E. L.; Burstyn, J. N.; J. Am. Chem. Soc. 1995, 117, 7015.         [ Links ]

17. Hegg, E. L.; Burstyn, J. N.; Inorg. Chem. 1996, 35, 7474.         [ Links ]

18. Parrilha, G. L.; Fernandes, C.; Bortoluzzi, A. J.; Szpoganicz, B.; Silva, M. S.; Pich, C. T.; Terenzi, H.; Horn, A., Jr.; Inorg. Chem. Commun. 2008, 11, 643.         [ Links ]

19. Mitic, N.; Smith, S. J.; Neves, A.; Guddat, L. W.; Gahan, L. R.; Schenk, G.; Chem. Rev. 2006, 106, 3338.         [ Links ]

20. Gavrilova, A. L.; Bosnich, B.; Chem. Rev. 2004, 104, 349;         [ Links ]

21. Gahan, L. R.; Smith, S. J.; Neves, A.; Schenk, G.; Eur. J. Inorg. Chem. 2009, 2745.         [ Links ]

22. Neves, A.; Lanznaster, M.; Bortoluzzi, A. J.; Peralta, R. A.; Casellato, A.; Castellano, E. E.; Herrald, P.; Riley, M. J.; Schenk, G.; J. Am. Chem. Soc. 2007, 129, 7486.         [ Links ]

23. Karsten, P.; Neves, A.; Bortoluzzi, A. J.; Drago, V.; Lanznaster, M.; Inorg. Chem. 2002, 41, 4624.         [ Links ]

24. Karsten, P.; Neves, A.; Bortoluzzi, A. J.; Strähle, J.; Maichle-Mössmer, C.; Inorg. Chem. Commun. 2002, 5, 434.         [ Links ]

25. Batista, S. C.; Neves, A.; Bortoluzzi, A. J.; Vencato, I.; Peralta, R. A.; Szpoganicz, B.; Aires, V. E.; Severino, P. A.; Inorg. Chem. Commun. 2003, 6, 1161.         [ Links ]

26. Lanznaster, M.; Neves, A.; Bortoluzzi, A. J.; Aires, V. V. E.; Szpoganicz, B.; Terenzi, H.; Severino, R. C.; Fuller, J. M.; Drew, S. C.; Gahan, L. R.; Hanson, G. R.; Riley, M. J.; Schenk, G.; J. Biol. Inorg. Chem. 2005, 10, 319.         [ Links ]

27. Schenk, G.; Peralta, R. A.; Batista, S. C.; Bortoluzzi, A. J.; Szpoganicz, B.; Dick, A. K; Herrald, P.; Hanson, G. R.; Szilagyi, R. K.; Riley, M. J.; Gahan, L. R.; Neves, A.; J. Biol. Inorg. Chem. 2008, 13, 139.         [ Links ]

28. Smith, S. J.; Casellato, A.; Hadler, K. S.; Mitić, N.; Riley, M. J.; Bortoluzzi, A. J.; Szpoganicz, B.; Schenck, G.; Neves, A.; Gahan, L.; J. Biol. Inorg. Chem. 2007, 12, 1207.         [ Links ]

29. Neves, A.; Brito, M. A.; Drago, V.; Griesar, K.; Haase, W.; Inorg. Chim. Acta 1995, 237, 131.         [ Links ]

30. Gonçalves, N. S.; Horn Jr., A.; Lanznaster, M.; Noda, L. K.; Neves, A.; J. Braz. Chem. Soc. 2006, 17, 1658.         [ Links ]

31. Smith, S. J.; Jovito, R.; Horn Jr., A.; Nascimento, O. R.; Noble, C. J.; Hanson, G. H.; Stranger, R.; Jayaratne, V.; Cavigliasso, G.; Gahan, L. R.; Schenk, G.; Neves, A.; Riley, M. J.; unpublished results.         [ Links ]

32. de Oliveira, I. R.W. Z.; Neves, A.; Vieira, I. C.; Sens. Actuators 2008, B 129, 424.         [ Links ]

33. Bernhardt, P. V.; Schenk, G.; Wilson, G.; J. Biochem. 2004, 43, 10387.         [ Links ]

34. Wang, D. L.; Holz, R. C.; David, S. S.; Que Jr., L.; Stankovich, M. T.; Biochemistry 1991, 30, 8187.         [ Links ]

35. Bunton, C. A.; Farber, S. J.; J. Org. Chem. 1969, 34, 767.         [ Links ]

36. Martell, A. E.; Motekaitis, R. J.; Determination of Stability Constants, 2^nd ed., VHC Publishers: Weinheim, Germany, 1992.         [ Links ]

37. Enraf-Nonius; CAD-4 EXPRESS; Version 5.1/1.2; Enraf-Nonius: Delft, The Netherlands, 1994.         [ Links ]

38. Spek, A.L.; HELENA; CAD-4 Data Reduction Program; Univ. of Utrecht, The Netherlands, 1996.         [ Links ]

39. Spek, A.L.; Acta Crystallogr. 1990, A46, C34.         [ Links ]

40. North, A. C. T.; Phillips, D. C.; Mathews, F. S.; Acta Crystallogr. 1968, A24, 351.         [ Links ]

41. Altomare, A.; Burla, M. C.; Camalli, M.; Cascarano, G.; Giacovazzo, C.; Guagliardi, A.; Moliterni, A.G.G.; Polidori, G.; Spagna, R.; J. Appl. Cryst. 1999, 32, 115.         [ Links ]

42. Sheldrick, G.M.; Acta Crystallogr. 2008, A64, 112.         [ Links ]

43. Neves, A.; Rossi, L. M.; Bortoluzzi, A. J.; Szpoganicz, B.; Wiezbicki, C.; Schwingel Haase, E.; Ostrovsky, W. S.; Inorg. Chem. 2002, 41, 1788.         [ Links ]

44. Peralta, R. A.; Neves, A.; Bortoluzzi, A. J.; dos Anjos, A.; Xavier, F. R.; Szpoganicz, B.; Terenzi, H.; de Oliveira, M. C. B.; Castellano, E.; Friedermann, G. R.; Mangrich, A. S.; Novak, M. A.; J. Inorg Biochem. 2006, 100, 992.         [ Links ]

45. Neves, A.; Rossi, L. M.; Bortoluzzi, A. J.; Haase, W.; Werner. R.; J. Braz. Chem. Soc. 2001, 12, 747.         [ Links ]

46. Gonzalez-Alvarez, M.; Alzuet, G.; Borras, J.; Macías, B.; Del Olmo, M.; Liu-Gonzalez, M. E.; Sanz, F.; J. Inorg. Biochem. 2002, 89, 29.         [ Links ]

47. Scarpellini, M.; Neves, A.; Hörner, R.; Bortoluzzi, A. J.; Szpoganicz, B.; Zucco, C.; Nome, R. A.; Drago, V.; Mangrich. A.S.; Ortiz, W. A.; Passos, W.A.; de Oliveira, M. C.; Terenzi, H.; Inorg. Chem. 2003, 42, 8353.         [ Links ]

48. Sreedhara, A.; Freed, J. D. E.; Cowan, J. A.; J. Am. Chem. Soc. 2000, 122, 8814.         [ Links ]

49. Brezova, V.; Valko, M.; Breza, H.; Morris, H.; Telser, J.; Dvoranova, D.; Kaiserova, K.; Varecka, L.; Mazur, M.; Leibfritz, D.; J. Phys. Chem. B 2003, 107, 2415.         [ Links ]

50. Macías, B.; Villa, M.V.; Gómez, B.; Borrás, J.; Alzuet, G.; González-Álvarez, M.; Castineiras, A.; J. Inorg. Biochem. 2007, 101, 444.         [ Links ]

51. Uytterhoeven, K.; Sponer, J.; Van Meervelt, L.; Eur. J. Biochem. 2002, 269, 2868.         [ Links ]

52. Lanznaster, M.; Neves, A.; Bortoluzzi, A. J.; Szpoganicz, B.; Schwingel, E.; Inorg. Chem. 2002, 41, 5641.         [ Links ]

53. Horn Jr, A.; Vencato, I.; Bortoluzzi, A.J.; Hörner, R.; Silva, R.A.N.; Szpoganicz, B.; Drago, V.; Terenzi, H.; Oliveira, M.C.B.; Werner, R.; Haase. W.; Neves, A.; Inorg. Chim. Acta 2005, 358, 339.         [ Links ]

54. Bornscheuer, U. T.; Kazlauskas, R. J.; Angew. Chem. Int. Ed. 2004, 43, 6032.         [ Links ]

55. Smith, S. J.; Noble, C. J.; Palmer, R. C.; Hanson, G. R.; Schenk, G.; Gahan, L. R.; Riley, M. J.; J. Biol. Inorg. Chem. 2008, 13, 499.         [ Links ]

56. Cowan, J. A.; Curr. Opin. Chem. Biol. 2001, 5, 634.         [ Links ]

57. Sreedhara, A.; Cowan, J. A.; J. Biol. Inorg. Chem. 2001, 6, 337.         [ Links ]

Received: October 1, 2009
Web Release Date: March 15, 2010

Supplementary Information